Analysts get more bullish on this non-tech stock

Eli Lilly has appointed Carolyn Bertozzi to its board of directors, effective December. Bertozzi is a renowned chemist and Nobel laureate, bringing significant expertise to the pharmaceutical company as it continues to expand its market presence.

Eli Lilly has become the first pharmaceutical company to achieve a market value of $1 trillion, driven by a nearly 40% surge in its shares this year. This growth is largely attributed to the strong demand for its weight-loss and diabetes medications, particularly GLP-1 drugs.

The Score is a weekly review highlighting significant stock movements and the news influencing them. This week, notable stocks include Nvidia, Constellation, Eli Lilly, and Gap, with Nvidia's performance particularly impacting market sentiment.

Eli Lilly, a 150-year-old pharmaceutical company based in Indianapolis, has become the first healthcare company to reach a market value of $1 trillion. This milestone is largely attributed to its success in the GLP-1 weight loss drug market, particularly with products like Zepbound and Mounjaro.

US consumer confidence has declined as stock markets continue to fall and shop prices remain high. The FTSE 100 index dropped by over 1%, reaching a one-month low, while the S&P 500 also experienced a significant decline after initial gains. Concerns about an AI bubble are resurfacing, contributing to market volatility.

Global stock markets, including Wall Street and Asian exchanges, faced significant declines this week as investors expressed concerns over a potential artificial intelligence bubble and inflation uncertainties. Major indices, such as the S&P 500, experienced their worst performance in months, prompting fears of a broader market downturn.

The stock markets experienced a downturn, with the S&P 500 erasing earlier gains after a promising start. The Dow Jones and Canada's S&P/TSX index also saw declines, reflecting growing concerns over artificial intelligence and interest rates.

The S&P 500 index is nearing its lowest point since September, despite Nvidia's strong earnings report that initially boosted market sentiment. The Nasdaq experienced a rise of over 2% at the start of the day, but these gains were quickly erased, reflecting ongoing market volatility and investor caution.